Ye et al. described a complex interaction axis consisting of FEZF1-AS1/miR-107/ZNF312B, which promotes the progression of pancreatic ductal adenocarcinoma (PDAC). Here, FEZF1 is linked to pancreatic ductal adenocarcinoma.